Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 5/20 | 0.34 |
| ▸ | EDNRA | P25101 | 6/20 | 0.34 |
| ▸ | EDNRB | P24530 | 4/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CDK8 | P49336 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.30 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1103001 | 0.89 | HTT (0.31) | KDM4ECDK8NPSR1 | |
| SCHEMBL1102524 | 0.89 | CDK8 (0.34) | KDM4ECDK8SMN1; SMN2 | |
| SCHEMBL13623238 | 0.88 | P2RX4 (0.34) | P2RX4L3MBTL1KDM4EATMCDK8 | |
| SCHEMBL13623242 | 0.87 | P2RX4 (0.38) | P2RX4KDM4EATMP2RX1P2RX3 | |
| SCHEMBL13623254 | 0.85 | CDK8 (0.34) | P2RX4EDNRAEDNRBATMCDK8 | |
| SCHEMBL13623247 | 0.85 | HSP90AA1 (0.38) | EDNRAEDNRBMAPTSMN1; SMN2NPSR1 | |
| SCHEMBL1103348 | 0.85 | CDK4 (0.34) | — | |
| SCHEMBL25648922 | 0.83 | ALDH1A1 (0.39) | P2RX4KDM4EATM | |
| SCHEMBL20026429 | 0.83 | P2RX4 (0.35) | P2RX4ATMP2RX1P2RX3MAPT | |
| SCHEMBL13158713 | 0.83 | CDK8 (0.31) | EDNRAEDNRBATMCDK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7619246-B2 | Organic light emitting compound and organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-11-17 | — | — | US | disclosed |
| US-7619246-B2 | Organic light emitting compound and organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-11-17 | — | — | US | disclosed |
| US-20070176541-A1 | Organic light emitting compound and organic light emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-08-02 | — | — | US | disclosed |
| US-20070176541-A1 | Organic light emitting compound and organic light emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070176541-A1 | Organic light emitting compound and organic light emitting device comprising the same | C1S, OR10J3, C1R | P2RX4 790/4885EDNRA 3090/4885EDNRB 3540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.